1. The List of Prokaryotic names with Standing in Nomenclature (LPSN): Genus
Helicobacter. https://www.bacterio.net/genus/helicobacter
last accessed 10th
October, 2020.
2. Saito S, Tsukahara M, Ohkusu K, Kurai H. Helicobacter fennelliae Bacteremia: Three
Case Reports and Literature Review. Medicine (Baltimore). 95(18): e3556, 2016.
3. Hamada T, Yokota K, Ayada K, Hirai K, Kamada T, Haruma K, Chayama K, Oguma
K. Detection of Helicobacter hepaticus in human bile samples of patients with biliary
disease. Helicobacter. 14(6): 545-51, 2009.
4. Segura-López FK, Avilés-Jiménez F, Güitrón-Cantú A, Valdéz-Salazar HA, LeónCarballo S, Guerrero-Pérez L, Fox JG, Torres J. Infection with Helicobacter bilis but
not Helicobacter hepaticus was Associated with Extrahepatic Cholangiocarcinoma.
Helicobacter. 20(3): 223-30, 2015.
5. Murata H, Tsuji S, Tsujii M, Fu HY, Tanimura H, Tsujimoto M, Matsuura N, Kawano
S, Hori M. Helicobacter bilis infection in biliary tract cancer. Aliment Pharmacol Ther.
20 Suppl 1: 90-4, 2004.
6. van der Vusse ML, van Son WJ, Ott A, Manson W. Helicobacter canis bacteremia in
a renal transplant patient. Transpl Infect Dis. 16(1): 125-9, 2014.
7. Abidi MZ, Wilhelm MP, Neff JL, Hughes JG, Cunningham SA, Patel R. Helicobacter
canis bacteremia in a patient with fever of unknown origin. J Clin Microbiol. 51(3):
1046-8, 2013.
8. Prag J, Blom J, Krogfelt KA. Helicobacter canis bacteraemia in a 7-month-old child.
FEMS Immunol Med Microbiol. 50(2): 264-7, 2007.
52
9. Alon D, Paitan Y, Ben-Nissan Y, Chowers M. Persistent Helicobacter canis
bacteremia in a patient with gastric lymphoma. Infection. 38(1): 62-4, 2010.
10. Kawamura Y, Tomida J, Morita Y, Fujii S, Okamoto T, Akaike T. Clinical and
bacteriological characteristics of Helicobacter cinaedi infection. J Infect Chemother.
20(9): 517-26, 2014.
11. Fennell CL, Totten PA, Quinn TC, Patton DL, Holmes KK, Stamm WE.
Characterization of Campylobacter-like organisms isolated from homosexual men. J
Infect Dis. 149(1): 58-66, 1984.
12. Totten PA, Fennell CL, Tenover FC, Wezenberg JM, Perine PL, Stamm WE, Holmes
KK. Campylobacter cinaedi (sp. nov.) and Campylobacter fennelliae (sp. nov.): two
new Campylobacter species associated with enteric disease in homosexual men. J
Infect Dis. 151(1): 131-9, 1985.
13. Vandamme P, Falsen E, Rossau R, Hoste B, Segers P, Tytgat R, De Ley J. Revision of
Campylobacter, Helicobacter, and Wolinella taxonomy: emendation of generic
descriptions and proposal of Arcobacter gen. nov. Int J Syst Bacteriol. 41(1): 88-103,
1991.
14. Misawa N, Kawashima K, Kondo F, Kushima E, Kushima K, Vandamme P. Isolation
and characterization of Campylobacter, Helicobacter, and Anaerobiospirillum strains
from a puppy with bloody diarrhea. Vet Microbiol. 87(4): 353-64, 2002.
15. Taniguchi T, Sekiya A, Higa M, Saeki Y, Umeki K, Okayama A, Hayashi T, Misawa
N. Rapid identification and subtyping of Helicobacter cinaedi strains by intact-cell
mass spectrometry profiling with the use of matrix-assisted laser desorption
ionization-time of flight mass spectrometry. J Clin Microbiol. 52(1): 95-102, 2014.
16. Sacks LV, Labriola AM, Gill VJ, Gordin FM. Use of ciprofloxacin for successful
53
eradication of bacteremia due to
Campylobacter cinaedi
in a
human
immunodeficiency virus-infected person. Rev Infect Dis. 13(6): 1066-8, 1991.
17. Decker CF, Martin GJ, Barham WB, Paparello SF. Bacteremia due to Campylobacter
cinaedi in a patient infected with the human immunodeficiency virus. Clin Infect Dis.
15(1): 178-9, 1992.
18. Kiehlbauch JA, Tauxe RV, Baker CN, Wachsmuth IK. Helicobacter cinaediassociated bacteremia and cellulitis in immunocompromised patients. Ann Intern Med.
121(2): 90-3, 1994.
19. Burman WJ, Cohn DL, Reves RR, Wilson ML. Multifocal cellulitis and
monoarticular arthritis as manifestations of Helicobacter cinaedi bacteremia. Clin
Infect Dis. 20(3):564-70, 1995.
20. Tee W, Street AC, Spelman D, Munckhof W, Mijch A. Helicobacter cinaedi
bacteraemia: varied clinical manifestations in three homosexual males. Scand J Infect
Dis. 28(2):199-203, 1996.
21. Sullivan AK, Nelson MR, Walsh J, Gazzard BG. Recurrent Helicobacter cinaedi
cellulitis and bacteraemia in a patient with HIV Infection. Int J STD AIDS. 8(1):5960, 1997.
22. Hung CC, Hsueh PR, Chen MY, Teng LJ, Chen YC, Luh KT, Chuang CY. Bacteremia
caused by Helicobacter cinaedi in an AIDS patients. J Formos Med Assoc. 96(7):
558-60, 1997.
23. Murakami H, Goto M, Ono E, Sawabe E, Iwata M, Okuzumi K, Yamaguchi K,
Takahashi T. Isolation of Helicobacter cinaedi from blood of an
immunocompromised patient in Japan. J Infect Chemother. 9(4): 344-7, 2003.
24. Simons E, Spacek LA, Lederman HM, Winkelstein JA. Helicobacter cinaedi
54
bacteremia presenting as macules in an afebrile patient with X-linked
agammaglobulinemia. Infection. 32(6) :367-8, 2004.
25. Uçkay I, Garbino J, Dietrich PY, Ninet B, Rohner P, Jacomo V. Recurrent bacteremia
with Helicobacter cinaedi: case report and review of the literature. BMC Infect Dis.
6: 86, 2006.
26. Kitamura T, Kawamura Y, Ohkusu K, Masaki T, Iwashita H, Sawa T, Fujii S, Okamoto
T, Akaike T. Helicobacter cinaedi cellulitis and bacteremia in immunocompetent
hosts after orthopedic surgery. J Clin Microbiol. 45(1): 31-8, 2007.
27. Kikuchi H, Asako K, Tansho S, Ueda T, Koshio O, Ubagai T, Asahara M, Kawakami
S, Ono Y. Recurrent Helicobacter cinaedi cellulitis and bacteremia in a patient with
systemic lupus erythematosus. Intern Med. 51(22): 3185-8, 2012.
28. Mandai S, Kasagi Y, Kusaka K, Shikuma S, Akita W, Kuwahara M. Helicobacter
cinaedi kidney cyst infection and bacteremia in a patient with autosomal dominant
polycystic kidney disease. J Infect Chemother. 20(11): 732-4, 2014.
29. Uwamino Y, Muranaka K, Hase R, Otsuka Y, Hosokawa N. Clinical Features of
Community-Acquired Helicobacter cinaedi Bacteremia. Helicobacter. 21(1): 24-8,
2016.
30. Sugiyama A, Mori M, Ishiwada N, Himuro K, Kuwabara S. First adult case of
Helicobacter cinaedi meningitis. J Neurol Sci. 336(1-2): 263-4, 2014.
31. Araoka H, Baba M, Kimura M, Abe M, Inagawa H, Yoneyama A. Clinical
characteristics of bacteremia caused by Helicobacter cinaedi and time required for
blood cultures to become positive. J Clin Microbiol. 52(5): 1519-22, 2014.
32. van der Ven AJ, Kullberg BJ, Vandamme P, Meis JF. Helicobacter cinaedi
bacteremia associated with localized pain but not with cellulitis. Clin Infect Dis.
55
22(4): 710-11, 1996.
33. Shimizu S, Shimizu H. Cutaneous manifestations of Helicobacter cinaedi: a review.
Br J Dermatol. 175(1): 62-8, 2016.
34. Taylor NS, Ge Z, Shen Z, Dewhirst FE, Fox JG. Cytolethal distending toxin: a
potential virulence factor for Helicobacter cinaedi. J Infect Dis. 188(12): 1892-7,
2003.
35. Laftah Z, Hay R. Helicobacter cinaedi - an emerging form of cellulitis. Br J
Dermatol. 175(1): 13-4, 2016.
36. Imafuku A, Araoka H, Tanaka K, Marui Y, Sawa N, Ubara Y, Takaichi K, Ishii Y,
Tomikawa S. Helicobacter cinaedi bacteremia in four renal transplant patients:
clinical features and an important suggestion regarding the route of infection.
Transpl Infect Dis. 18(1): 132-6, 2016.
37. Matsumoto T, Goto M, Murakami H, Tanaka T, Nishiyama H, Ono E, Okada C,
Sawabe E, Yagoshi M, Yoneyama A, Okuzumi K, Tateda K, Misawa N, Yamaguchi
K. Multicenter study to evaluate bloodstream infection by Helicobacter cinaedi in
Japan. J Clin Microbiol. 45(9): 2853-7, 2007.
38. Miyake N, Chong Y, Nishida R, Nagasaki Y, Kibe Y, Kiyosuke M, Shimomura T,
Shimono N, Shimoda S, Akashi K. A dramatic increase in the positive blood culture
rates of Helicobacter cinaedi: the evidence of differential detection abilities between
the Bactec and BacT/Alert systems. Diagn Microbiol Infect Dis. 83(3): 232-3, 2015.
39. Baron EJ, Weinstein MP, Dunne Jr. WM, Yagupsky P, Welch DF, Wilson DM.
Cumitech 1C, blood cultures IV. Washington, DC; ASM Press, 2005.
40. Kitamura T, Kawamura Y, Ohkusu K, Masaki T, Iwashita H, Sawa T, Fujii S,
Okamoto T, Akaike T. Helicobacter cinaedi cellulitis and bacteremia in
56
immunocompetent hosts after orthopedic surgery. J Clin Microbiol. 45(1): 31-8,
2007.
41. Minauchi K, Takahashi S, Sakai T, Kondo M, Shibayama K, Arakawa Y, Mukai M.
The nosocomial transmission of Helicobacter cinaedi infections in
immunocompromised patients. Intern Med. 49(16): 1733-9, 2010.
42. Rimbara E, Mori S, Kim H, Matsui M, Suzuki S, Takahashi S, Yamamoto S, Mukai
M, Shibayama K. Helicobacter cinaedi and Helicobacter fennelliae transmission in
a hospital from 2008 to 2012. J Clin Microbiol. 51(7): 2439-42, 2013.
43. Khan S, Rahman HN, Okamoto T, Matsunaga T, Fujiwara Y, Sawa T, Yoshitake J,
Ono K, Ahmed KA, Rahaman MM, Oyama K, Takeya M, Ida T, Kawamura Y, Fujii
S, Akaike T. Promotion of atherosclerosis by Helicobacter cinaedi infection that
involves macrophage-driven proinflammatory responses. Sci Rep. 4: 4680, 2014.
44. Hannula M, Hänninen ML. Phylogenetic analysis of Helicobacter species based on
partial gyrB gene sequences. Int J Syst Evol Microbiol. 57(Pt 3): 444-9, 2007.
45. Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP, Lamm W,
Clark C, MacFarquhar J, Walton AL, Reller LB, Sexton DJ. Health care-associated
bloodstream infections in adults: a reason to change the accepted definition of
community-acquired infections. Ann Intern Med. 137(10): 791–7, 2002.
46. Rimbara E, Mori S, Matsui M, Suzuki S, Wachino J, Kawamura Y, Shen Z, Fox JG,
Shibayama K. Molecular epidemiologic analysis and antimicrobial resistance of
Helicobacter cinaedi isolated from seven hospitals in Japan. J Clin Microbiol. 50(8):
2553-60, 2012.
47. Taniguchi T, Saeki Y, Okayama A, Hayashi T, Misawa N. Extraintestinal infection of
Helicobacter cinaedi induced by oral administration to Balb/c mice. Microbiol
57
Immunol. 61(2): 57-63, 2017.
48. Gibson JR, Sutherland K, Owen RJ. Inhibition of DNAse activity in PFGE analysis
of DNA from Campylobacter jejuni. Lett Appl Microbiol. 19: 357-358, 1994.
49. Zhou P, Oyarzabal OA. Application of pulsed field gel electrophoresis to type
Campylobacter jejuni. In Jordan K, Dalmasso M (ed), Pulse Field Gel
Electrophoresis: Methods and Protocols, Methods in Molecular Biology, vol. 1301.
Humana Press, Springer Science + Business Media New York 2015, 2011: 139-56.
50. Tomida J, Morita Y, Shibayama K, Kikuchi K, Sawa T, Akaike T, Kawamura Y.
Diversity and microevolution of CRISPR loci in Helicobacter cinaedi. PLoS One.
12(10): e0186241, 2017.
51. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying
prognostic comorbidity in longitudinal studies: development and validation. J Chronic
Dis. 40(5): 373-83, 1987.
52. Chow JW, Yu VL. Combination antibiotic therapy versus monotherapy for Gramnegative bacteraemia: a commentary. Int J Antimicrob Agents. 11: 7–12, 1999.
53. Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, Raad II,
Rolston KV, Young JA, Wingard JR; Infectious Diseases Society of America.
Clinical practice guideline for the use of antimicrobial agents in neutropenic patients
with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect
Dis. 52: e56–e93, 2011.
54. US Department of Health and Human Services; National Institutes of Health.
National Cancer Institute Common Terminology Criteria for Adverse Events
(CTCAE) Version 4.03, June 14, 2010. Available at:
https://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03/CTCAE_4.03_2010-06-
58
14_QuickReference_8.5x11.pdf Accessed 12 October 2020.
55. Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical
statistics. Bone Marrow Transplant. 48: 452-8, 2013.
56. 西尾久明, 浅越康助. Helicobacter cinaedi による菌血症後、腸炎発症時の腸管
粘膜から病理学的・細菌学的に同菌を検出したびまん性大細胞型 B 細胞リ
ンパ腫の 1 症例. 感染症誌. 92; 133-7, 2018.
57. Olnes MJ, Kotliarov Y, Biancotto A, Cheung F, Chen J, Shi R, Zhou H, Wang E, Tsang
JS, Nussenblatt R; CHI Consortium. Effects of systemically administered
hydrocortisone on the human immunome. Sci Rep. 6: 23002, 2016.
58. Franchimont D, Louis E, Dewe W, Martens H, Vrindts-Gevaert Y, De Groote D,
Belaiche J, Geenen V. Effects of dexamethasone on the profile of cytokine secretion
in human whole blood cell cultures. Regul Pept. 73(1): 59-65, 1998.
59. Fauci AS, Dale DC, Balow JE. Glucocorticosteroid therapy: mechanisms of action
and clinical considerations. Ann Intern Med. 84(3): 304-15, 1976.
60. Settipane GA, Pudupakkam RK, McGowan JH. Corticosteroid effect on
immunoglobulins. J Allergy Clin Immunol. 62(3): 162-6, 1978.
61. Waljee AK, Rogers MA, Lin P, Singal AG, Stein JD, Marks RM, Ayanian JZ,
Nallamothu BK. Short term use of oral corticosteroids and related harms among
adults in the United States: population based cohort study. BMJ. 357: j1415, 2017.
62. Stuck AE, Minder CE, Frey FJ. Risk of infectious complications in patients taking
glucocorticosteroids. Rev Infect Dis. 11(6): 954-63, 1989.
63. Lasry S, Simon J, Marais A, Pouchot J, Vinceneux P, Boussougant Y. Helicobacter
cinaedi septic arthritis and bacteremia in an immunocompetent patient. Clin Infect
Dis. 31(1): 201-2, 2000.
59
64. Silvestri L, van Saene HK. Selective decontamination of the digestive tract: an update
of the evidence. HSR Proc Intensive Care Cardiovasc Anesth. 4(1): 21-9, 2012.
65. Daneman N, Sarwar S, Fowler RA, Cuthbertson BH; SuDDICU Canadian Study
Group. Effect of selective decontamination on antimicrobial resistance in intensive
care units: a systematic review and meta-analysis. Lancet Infect Dis. 13(4): 328-41,
2013.
66. Kiehlbauch JA, Brenner DJ, Cameron DN, Steigerwalt AG, Makowski JM, Baker CN,
Patton CM, Wachsmuth IK. Genotypic and phenotypic characterization of
Helicobacter cinaedi and Helicobacter fennelliae strains isolated from humans and
animals. J Clin Microbiol. 33(11): 2940-7, 1995.
67. Aboelatta YA, Abd-Elsalam AM, Omar AH, Abdelaal MM, Farid AM. Selective
digestive decontamination (SDD) as a tool in the management of bacterial
translocation following major burns. Ann Burns Fire Disasters. 26(4): 182-8, 2013.
68. Okada H, Kitazawa T, Harada S, Itoyama S, Hatakeyama S, Ota Y, Koike K.
Combined treatment with oral kanamycin and parenteral antibiotics for a case of
persistent bacteremia and intestinal carriage with Campylobacter coli. Intern Med.
47(14): 1363-6, 2008.
69. Fujiya Y, Nagamatsu M, Tomida J, Kawamura Y, Yamamoto K, Mawatari M, Kutsuna
S, Takeshita N, Hayakawa K, Kanagawa S, Mezaki K, Hashimoto M, Ishii S,
Ohmagari N. Successful treatment of recurrent Helicobacter fennelliae bacteraemia
by selective digestive decontamination with kanamycin in a lung cancer patient
receiving chemotherapy. JMM Case Rep. 3(5): e005069, 2016.
70. Sawada O, Gotoh Y, Taniguchi T, Furukawa S, Yoshimura D, Sasaki S, Shida H,
Kusunoki Y, Yamamura T, Furuya K, Itoh T, Horita T, Hayashi T, Misawa N. Genome
60
sequencing verifies relapsed infection of Helicobacter cinaedi. Open Forum Infect
Dis. 6(5): ofz200, 2019.
71. Orlicek SL, Welch DF, Kuhls TL. Septicemia and meningitis caused by Helicobacter
cinaedi in a neonate. J Clin Microbiol. 31: 569-71, 1993.
72. Tomida J, Oumi A, Okamoto T, Morita Y, Okayama A, Misawa N, Hayashi T, Akaike
T, Kawamura Y. Comparative evaluation of agar dilution and broth microdilution
methods for antibiotic susceptibility testing of Helicobacter cinaedi. Microbiol
Immunol. 57(5): 353-8, 2013.
73. Kawamura Y, Tomida J, Miyoshi-Akiyama T, Okamoto T, Narita M, Hashimoto K,
Cnockaert M, Vandamme P, Morita Y, Sawa T, Akaike T. Proposal of Helicobacter
canicola sp. nov., previously identified as Helicobacter cinaedi, isolated from canines.
Syst Appl Microbiol. 39(5): 307-12, 2016.
61
...
論文の公開元へ
